We assessed diagnostic and prognostic value of CEACAM1 as a non-invasive serological biomarker and we found that serum and tissue CEACAM1 were significantly elevated in OS patients and elevated serum CEACAM1 level was correlated with lower tumor grade, more advanced clinical stage and distant metastases. Here, CEACAM1 is linked to neoplasm.